This ASX infant formula share just reported explosive growth. Could it be the next a2 Milk?

Could Nuchev Ltd (ASX: NUC) become the next A2 Milk Company Ltd (ASX: A2M)?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Nuchev Ltd (ASX: NUC) shares are up 3.79% today on the release of a strong quarterly report this morning. A relatively new ASX infant formula player, Nuchev is an Australian based, globally orientated food business with a dedicated focus on developing, marketing and selling a range of premium Australian-made goat nutritional products.

Nuchev's primary products include its Oli6 branded goat infant formula and nutritional range, which are sold across multiple sales channels in Australia, China and Hong Kong. 

Explosive quarterly report 

Earlier today, Nuchev provided a 3rd quarter activity report for the period ending 31 March 2020. It highlighted continued sales momentum of its Oli6 goat-milk infant formula and nutritional products, with significant revenue and volume growth across key distribution channels. 

Despite the coronavirus pandemic, the company delivered all-time record sales and an all-time record sales month in March 2020. It notes that it has not experienced any adverse material impacts as a result of COVID-19 and that the strong market demand has been capably met by Nuchev's supply chain. 

Volumes and net revenue for the 9 months ending March 2020 increased by approximately 168% and 155%, respectively, on the previous corresponding period (pcp). Its revenue during this period soared from $5.1 million in the pcp to $13.0 million. Nuchev currently has a market capitalisation just shy of $100 million, which places the company at a relatively low sales multiple. 

Its sales momentum is driven by its key sales channels of cross border e-commerce, pharmacy and grocery partners. Nuchev submitted its brand application to sell Chinese specification Oli6 product in the offline channel to the State Administration for Market Regulation (SAMR) in 2018. It notes that some brands manufactured in Europe recently received approval, and remains confident that the process will progress to a positive outcome. Should it receive approval, investors can expect a significant volume and revenue boost.

Given Nuchev's recent IPO, the company is in a strong cash position with $13 million cash on hand with no debt. The company is showing improvements in its cash flows but still operating at a loss. 

Could it be the next A2 Milk?

The A2 Milk Company Ltd (ASX: A2M) had similar humble beginnings. However, Nuchev's strong performance today is by no means a guarantee that it will become an infant formula giant. One of my personal criticisms is that goat milk is a niche market and not all consumers may be inclined to consume goat-milk related products. The market opportunity at hand may be smaller than cows milk. 

That said, Nuchev is making a move in the right direction. The company has achieved very strong growth results with no significant supply chain issues amidst all this chaos. The SAMR application approval could serve as a catalyst for its revenues and share price to reach new highs, however there is an inherent risk as it could be rejected/delayed. Overall, I believe it has potential and is a stock worth having on your watchlist. 

Motley Fool contributor Lina Lim has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Share Gainers

These were the best-performing ASX 200 shares in March

These shares made their shareholders smile in March thanks to some very big gains.

Read more »

Businessman using a digital tablet with a graphical chart, symbolising the stock market.
Opinions

2 ASX shares I have been buying in 2024!

I’m a believer in the long-term outlook of these stocks.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

a young boy dressed up in a business suit and tie has a cute grin and holds two fingers up.
Opinions

2 of my top ASX 200 shares to consider buying before April

I would happily exchange dollars for these two shares right now.

Read more »